SALLSTIG, PETER,SCHMIDT, WERNER,GEKKIEVA, MARGARITA,WARBURTON, JAMES,WEICHSELBERGER, ANDREAS
申请号：
CA2966646
公开号：
CA2966646A1
申请日:
2015.11.06
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
A method is provided for reducing the treatment burden for patients who have an intraocular neovascular disorder, the method comprising administering a therapeutically effective amount of VEGF antagonist on a dosing schedule that includes treatment intervals of 8 and/or 12 weeks.
